Sign up
Pharma Capital
EPIC: PCGH
Market: LSE
52-week High/Low: 230.00p / 175.50p
Sector: Health Care, Equipment & Services
Market Cap: 260.86M

Polar Capital is a specialist, investment-led, active fund manager with a collegiate and meritocratic culture where capacity of investment strategies is managed to enhance and protect performance. Since its foundation in 2001, it has grown steadily and currently has 12 autonomous investment teams managing specialist, active and capacity constrained portfolios, with combined AUM of...

Polar Capital Global Healthcare Trust PLC

www.polarcapitalhealthcaretrust.com

Interactive graph

col 3
col 4
col 5
col 6

Polar Capital Global Healthcare Trust PLC Snapshot

Group Strategy

Polar Capital’s goal is to become a leading specialist fund management company through a strategy of delivering to professional and institutional investors a range of fundamentally-driven investment products that deliver differentiated risk-adjusted returns over the long term. Our core philosophy is to focus on investment performance over and above the gathering of assets. We believe there is an alignment of interest between the investment managers we recruit, their focus on delivering superior returns and the interests of professional and institutional clients who are seeking differentiated investment products.

In addition to providing clients with superior investment products, we place great emphasis on providing high levels of customer service, operational integrity, independent risk control and compliance supervision. We believe such a combination will increasingly differentiate us in the marketplace and deliver attractive levels of long-term earnings and dividend growth to our shareholders.

We place great emphasis on providing and maintaining an entrepreneurial, vibrant, collegiate and transparent environment for our fund managers and our employees. We believe this will become an increasingly important factor in the attraction and retention of talented people.

Polar Capital will continue to maintain a strong and healthy balance sheet providing our clients with added comfort during turbulent times.

James Robinson
Chairman


James was chief investment officer, investment trusts and director of hedge funds at Henderson Global Investors prior to his retirement in 2005. A chartered accountant, he has 30 years’ investment experience and is currently a director of JP Morgan Elect plc, Invesco Asia Trust plc, Montanaro UK Smaller Companies Investment Trust plc and Fidelity European Values PLC.

Anthony Brampton
Director


Tony has a BA and a MSc in Biochemistry from Oxford University. He joined Fielding, Newson-Smith & Co. as an analyst in 1985, then worked at Wood Mackenzie & Co. and Morgan Stanley International. In 1989 he joined Cazenove & Co. and became a partner in 1999. He was managing director, corporate finance at JPMorgan Cazenove, with responsibility for healthcare, prior to his retirement in June 2006. He is currently a partner at Sudbrook Associates LLP and a non-executive director of Abzena plc and Domainex Limited.

Neal Ransome
Director
Appointed to the Board on 13 December 2017.

Neal was a partner at PwC from 1996 to 2013. He led PwC's Pharmaceutical and Healthcare M&A practice for 17 years, and was also chief operating officer of PwC's Advisory Services business. A chartered accountant with an MA in Modern History from Oxford University. Neal is currently chairman of ProVen VCT Plc and a non-executive director and chair of the audit committee of Octopus AIM VCT Plc. He is also a trustee and council member of the RSPB, the UK's largest nature conservation charity.

Lisa Arnold
Director
Appointed to the Board on 1 February 2018.

Ms Arnold was formerly a global pharmaceuticals and healthcare analyst. Ms Arnold holds a number of trustee directorships and is the chairman of the Allied Domecq Pension Fund as well as chairman of its investment committee. She is also a non-executive director and chairman of the audit committee of PIMCO Europe Limited.

Company Registrar
Equiniti Limited
Aspect House
Spencer Road
Lancing
West Sussex
BN99 6DA

Helpline: 0800 313 4922
www.shareview.co.uk

Company Registration Number
7251471 (Registered in England)
The Company is an investment company as defined under Section 833 of the Companies Act 2006.

Shareholder Contacts

Company Registrar
Equiniti Limited
Aspect House
Spencer Road
Lancing
West Sussex
BN99 6DA

Helpline: 0800 313 4922
www.shareview.co.uk

Company Registration Number
7251471 (Registered in England)
The Company is an investment company as defined under Section 833 of the Companies Act 2006.

General Enquiries

Company Secretary
Polar Capital Secretarial Services Limited
Represented by Tracey Lago ACIS

The Company Secretary can be contacted at the Registered Office.

Registered Office and Contact Address for Directors
16 Palace Street
London
SW1E 5JD

Telephone: +44 (0) 20 7227 2700
Fax: +44 (0) 20 7227 2799
[email protected]

Investment Manager and AIFM
Polar Capital LLP
16 Palace Street
London
SW1E 5JD

Authorised and Regulated by the Financial Conduct Authority

Telephone: 020 7227 2700
Website: www.polarcapital.co.uk

Depository, Bankers and Custodian
HSBC Bank Plc
8 Canada Square
London
E14 5HQ

Independent Auditors
PricewaterhouseCoopers LLP
Atria One
144 Morrison Street
Edinburgh
EH3 8EX

Solicitors
Herbert Smith Freehills LLP
Exchange House
Primrose Street
London
EC2A 9AF

View full PCGH profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.